Nothing Special   »   [go: up one dir, main page]

Dash et al., 1991 - Google Patents

Solid-state properties of tobramycin

Dash et al., 1991

Document ID
15013354640961629940
Author
Dash A
Suryanarayanan R
Publication year
Publication venue
Pharmaceutical research

External Links

Snippet

Tobramycin (I) obtained from two different sources was subjected to powder X-ray diffractometry, thermal analyses, and Karl Fischer titrimetry. It was concluded to be tobramycin monohydrate (C 18 H 37 N 5 O 9· H 2 O). When heated in the differential …
Continue reading at link.springer.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Similar Documents

Publication Publication Date Title
Dash et al. Solid-state properties of tobramycin
CN108864077B (en) Solid form of berberine organic acid salt and preparation method thereof
Caira et al. Structural characterization, physicochemical properties, and thermal stability of three crystal forms of nifedipine
BRPI0714886A2 (en) fast-acting benzodiazepine salts and their polymorphic forms
Censi et al. Sodium ibuprofen dihydrate and anhydrous: study of the dehydration and hydration mechanisms
JP2022550374A (en) Novel salts of terphenyl compounds
AU2016204902A1 (en) Novel forms of bendamustine free base
EP4073036B1 (en) Crystalline form of a 7h-benzo[7]annulene-2-carboxylic acid derivative
KR100329156B1 (en) Dihydrate of Alpzosin Hydrochloride
Bianco et al. Modification of the solid-state nature of sulfathiazole and sulfathiazole sodium by spray drying
CZ138297A3 (en) Novel physically stable form of solid fluoroquinolone
Qian et al. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 3: effect of moisture
Neglur et al. Water and the relationship to the crystal structure stability of azithromycin: Thermal investigations of solvatomorphism, amorphism and polymorphism
MXPA97003622A (en) A new solid form physically stable in unafluoroquinol
Chongprasert et al. Effects of freeze-dry processing conditions on the crystallization of pentamidine isethionate
CN115433246B (en) Crystal form, preparation method and application of glucosamine derivative
Yang et al. Insight into a direct solid–solid transformation: a potential approach for the removal of residual solvents
JP2020512379A (en) A crystalline form of (S)-[2-chloro-4-fluoro-5- (7-morpholin-4-ylquinazolin-4-yl) phenyl]-(6-methoxy-pyridazin-3-yl) methanol.
Yang et al. Thermodynamic stability analysis of m-nisoldipine polymorphs
Li et al. Polymorphism and crystallization behavior of Abbott‐79175, a second‐generation 5‐lipoxygenase inhibitor
Sohn et al. Crystal forms of ketorolac
WO2021008486A1 (en) Novel muscle relaxant antagonistic compounds
WO2018001335A1 (en) Crystal forms of nbi-98854, preparation method therefor and use thereof
BR112021014327A2 (en) CRYSTALLINE FORM OF 1,2,3-TRIAZOLO[1,5-A]PYRAZINES DERIVATIVES, METHOD OF PREPARATION OF SUCH CRYSTALLINE FORM, PHARMACEUTICAL COMPOSITIONS COMPRISING IT AND ITS USE
CN117003702B (en) Fluocytosine-orotate and preparation method and application thereof